Communicating, Educating, and Triage for Patients Receiving Bispecific Antibodies in RRMM.
CE Information: 0.25 ANCC nursing contact hour | 0.25 AAPA Category 1 CME Credit
Available: June 26, 2026 – December 26, 2026
This activity is jointly provided by Medical Education Resources and QDcme.
This activity is supported by an educational grant from Johnson & Johnson.
Explore the latest data on bispecific antibodies in multiple myeloma, along with patient selection strategies, toxicity management, and workflow integration so you can confidently incorporate bispecific antibodies into everyday care.
Target Audience
The proposed CME activities will be designed to meet the professional educational needs of advanced practice providers including nurse practitioners, physician associates and advanced oncology nurses who treat and/or manage patients with multiple myeloma.
This on-demand activity is designed to equip advanced practice providers and oncology nurses with practical strategies to communicate, educate, and triage patients receiving bispecific antibodies for relapsed/refractory multiple myeloma (RRMM). Through expert guidance, learners will strengthen their ability to explain bispecific therapies in clear, patient-centered language, facilitate shared decision-making, and recognize early signs of treatment-related toxicities.
The program emphasizes real-world tools and streamlined triage approaches that support patient safety, adherence, and timely intervention across community oncology settings.
After participating in this education, learners will be able to:
Kevin Brigle
PhD, ANP
Oncology Nurse Practitioner
VCU Massey Comprehensive Cancer Center
Richmond, VA
Beth Faiman
PhD, MSN, APN-BC, AOCN®, TCTCN®,FAAN, FAPO
Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Population and Cancer Prevention Program
Cleveland, OH
Medical Education Resources designates this live activity for a maximum of 0.25 ANCC nursing contact hour. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 0.25 contact hour.
Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME Credit. Physician Associates should only claim credit commensurate with the extent of their participation.
MER ensures balance, independence, objectivity, and scientific rigor in all educational activities. Relevant financial relationships are identified and mitigated by MER.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
Kevin Brigle, PhD, ANP
Consultant: Janssen, J&J
Speaker: Astra Zeneca, BMS, Karyopharm, Pfizer, Sanofi
Beth Faiman PhD, MSN, APN-BC, AOCN®,TCTCN®,FAAN, FAPO
Consultant: Sanofi, Janssen, GSK, Pfizer
The content managers reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
Planners at QDcme
No relevant financial relationships to disclose.
Sara DiCamillo, PA-C, MPH: No relevant financial relationships to disclose.
Planners at Medical Education Resources
No relevant financial relationships to disclose.
Internet
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, QDcme, and Johnson & Johnson.
There is no fee for this educational activity.
Medical Education Resources and QDcme maintain high standards for the protection of privacy over the Internet.
The only information MER obtains is information supplied voluntarily by the visitor.
We do not sell or disclose individually identifiable information obtained online unless required by law or to protect the safety of customers, employees, or property.
We use the information to grade your posttest and to issue a certificate of completion of the activity. If we use a third-party company to grade your posttest and issue certificates, we will give the information to that company for that purpose only.
For each activity that you take, you must complete an evaluation questionnaire. That questionnaire may ask if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the information to invite you to participate in other activities that we may offer.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, MER will not share the names or contact information of learners with any ineligible company or its agents without the explicit consent of the individual learner.
Medical Education Resources is committed to safeguarding customer privacy, and we require our employees to protect the privacy of information about our customers. Should you wish to delete your information from our files or discuss our privacy policy, please contact us.
Click here to read our Privacy Policy.
